March 12, 2012 — Diagnosis of polymyalgia rheumatica (PMR) has started to move from the realm of clinical intuition toward a more objective approach, after the release of provisional classification ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Diagnosing giant cell arteritis and polymyalgia rheumatica can “fascinate” and cause “trepidation” ...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) announced a $1.6 million four-year grant from the Centers for Disease Control and Prevention (CDC) to enhance awareness ...

Researchers in Leeds say PMR is underdiagnosed and undertreated in the north of England.

Dear Dr. Roach: I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which ...

Background: the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking. As a result, there is no evidence from ...

Polymyalgia rheumatica (PMR) is a systemic inflammatory disorder that predominantly affects individuals over the age of 50. It is characterised by pain and stiffness in the shoulder and hip girdles, ...

Three years after enrolling its first patients, a consortium of researchers examining the growing issue of immune-related adverse events due to immune checkpoint inhibitor cancer therapy released a ...

DEAR DR. ROACH: I think my 75-year-old husband has polymyalgia rheumatica, and I understand it has no definitive cause. He gets severe unbearable pain alternating between his neck and hips every few ...

(RTTNews) - Novartis (NVS,NOVN.SW) announced that its interleukin-17A inhibitor Cosentyx (secukinumab) met the primary and all secondary endpoints in the Phase III REPLENISH trial. The study evaluated ...

The Global Healthy Living Foundation (GHLF) is excited to present innovative and transformative research at the American College of Rheumatology (ACR) Convergence 2024 in Washington DC. This marks ...